
novavex covid-19 teeka

novax covid-19 teeka, jise anya brand naamon key tahat becha jaataa haye, novaxvid aur covovax, ack upa-ikai covid-19 teeka haye jise novax aur mahamari taiyari navacharon (see. pee. aaee.) key liye gathbandhan dwara vikasit kiya gayaa haye. nuvaxovid key nirnaayak charan III pareekshan key poorna parinam disambar 2021 mein prakaashit kiye gaye they.
chikitsa upayog.
saars-cove-2 key kaaran honey vaale covid-19 koo rokane key liye sakriya teekaakaran key liye novavex covid-19 vaccine kaa sanket diyaa gayaa haye.
prabhavkarita.
ack teeka aam taur parr prabhaavi maanaa jaataa haye yadi anuman 95 pratishat aatmavishvaas antaral kii 30 pratishat seey cumm seema key saath 50 pratishat seey cumm haye. prabhavkarita prabhavsheelta seey nikatata seey sambandhit haye, joe aam taur parr samay key saath dheere-dheere cumm honey kii ummeed haye.
disambar 2021 mein, novavex ney bataaya kii isake charan III pareekshan seey pataa chalaa kii vaccine ney doosari khuraak key cumm seey cumm saat dinn baad sankraman koo rokane key apane praathamik antim bindu koo hassil curr liya haye. vibhinn saars-cove-2aiss key khilaf samagr prabhavkarita 90.4% thee aur madhyam seey gambhir roga key khilaf prabhavkarita 100% thee.
saars-cove-2 omicron sanskaran key udbhav seey pahale pareekshan kiye gaye they, jisane sankraman koo rokane mein adhikrit teekon kii prabhavsheelta koo teji seey cumm curr diyaa haye.
dushprabhaav.
sabse aam dushprabhavon mein bukhaar, sirdard, matali, maanspeshiyon aur jodon mein dard, injection sthal parr komalata aur dard, thakan aur aswasth mahsoos karna shamil hain.
atirikt sambhaavit dushprabhavon mein anaphylaxis (gambhir allergy pratikriya), peresthesia (twacha mein asamanya bhavna, jaise jhunjhuni yaa rengane kii sansani) aur hypoesthesia (vishesh roop seey twacha mein bhavna yaa samvedansheelta mein kamee), aur pericarditis (hriday key aspas astar kii soojan) shamil hain.
27 janwari 2023 koo, australia key chikitsiya saman prashaasan ney sanket diyaa kii yeh apane label mein tinitus jodd dega.
prabandhan aur prashaasan.
teeke key liye dou khuraakon kii aavashyakta hoti haye aur yeh prasheetit tapman parr sthir haye. 
praudyogiki.
nvx-cove2373 koo ack protein upa-ikai teeka aur ack virus jaise kann teeka donon key roop mein varnit kiya gayaa haye, halanki utpaadak ise "punah sanyojak nainokan teeka" kahate hain.
ack sanshodhit saars-cove-2 spike protein key liye ack jeane yukt ack engineer baculovirus banaakar teeke kaa utpaadan kiya jaataa haye. spike protein koo protein key poorv-sanlayan roop koo sthir karane key liye dou proline amino acid koo shamil karke sanshodhit kiya gayaa thaa; isi 2pee sanshodhan kaa upayog kaee anya covid19 teekon mein kiya jaa rhaa haye. baculovirus koo aiss. aff. 9 patang koshikaon key culture koo sankramit karane key liye banaaya jaataa haye, joe phir spike protein banaata haye aur ise apani koshika jhilli parr pradarshit kartaa haye. spike proteins koo kaataa jaataa haye aur lagbhag 50 nanometer key synthetic lipid nanopartical parr ikattha kiya jaataa haye, jinamen seey pratyek 14 spike protein taka pradarshit kartaa haye.
sutrikaran mein matricks-aim naamak saponin-adharit sahayak shamil haye.
vinirmaan.
24 farwari 2021 koo, novavex ney japan mein teeke key nirmaan key liye takeda key saath bhagidari kii, jahan isake covid19 teeke koo taak-019 key roop mein jaanaa jaataa haye.
novavex ney vikaasheel aur cumm aaya vaale deshon key liye badey paimaane parr utpaadan key liye seeram institute off india key saath ack samjhaute parr hastakshar kiye. 2020 mein yeh bataaya gayaa thaa kii vaccine kaa nirmaan spen mein kiya jaayega aur navambar 2021 mein ise mabian company dwara polland mein utpaadit kiye jaane kii soochana dee gaee thee. 2021 taka, check ganarajya mein novavex key karkhane novavex seased mein antigen banaae gaye they; novavex seased isake eu pradhikaran kaa vipanan pradhikaran dhaarak bhee thaa.
maee 2021 mein, seeram institute off india ney kahaa kii usane bhaarat sarkaar seey anumati praapt karane key baad bhaarat mein "covavax" key roop mein branded novvax covid19 vaccine kaa utpaadan shuru kiya.
itihas.
janwari 2020 mein, novavex ney saars-cove-2 key prati pratiraksha sthaapit karane key liye nvx-cove2373 kodnem vaale ack vaccine ummidwar key vikas kii ghoshana kii. novavex kaa kaam darjanon anya companiyon key beach vaccine vikas key liye pratispardha mein haye.
march 2020 mein, novavax ney vaccine ummidwar parr poorv naidaanik aur praarambhik charan key maanav anusandhaan key liye ubharate jaiv samadhanon key saath sahyog kii ghoshana kii. saajhedaari key tahat, ubharate hue jaiv-samadhanon koo apane baltimore suvidha mein badey paimaane parr teeke kaa nirmaan karna thaa. haalaanki, apane baltimore sanyantra mein johnson aind johnson aur oxford-astrazeneca teekon key saath utpaadan key muddon key baad aur sanyantra parr bojh koo cumm karane key liye, novavex ney baad mein yuu dwara paryavekshit ack nae samjhaute mein ack alag nirmaata key saath bhagidari kii.aiss. sarkaar.
united kingdam mein bhee pareekshan hue hain. ummidwar kaa pahala maanav suraksha adhyayan, nvx-cove2373 kodnem, maee 2020 mein australia mein shuru huaa.
julaai 2020 mein, company ney ghoshana kii kii aggar naidaanik parikshanon seey pataa chalata haye kii teeka prabhaavi haye tou 2021 taka apane coronavirus vaccine ummidwar key vikas mein teji laane key liye usey operation warp gati seey praapt hoe sakata haye. novavex key ack pravakta ney kahaa kii 1.6 arab dollar swaasthya aur maanav seva vibhaag aur raksha vibhaag key beach ack "sahyog" seey aaa rahey they, jahaan samanya roop seey aff. parna koo warp gati key liye kuu key roop mein chunaa gayaa haye. sitambar key anta mein, novavex ney britten mein apane coronavirus teeke key pareekshan key antim charan mein pravesh kiya. america mein octuber taka ack aur badey pareekshan kii ghoshana kii gaee thee.
naidaanik pareekshan.
charan I aur II.
26 maee 2020 koo, melburn mein ack ummidwar covid19 vaccine, novavex key nvx-cove2373 kaa australia kaa pahala maanav pareekshan shuru huaa. isamen 18-59 key beach kii ayu key lagbhag 130 swayamsevak shamil they.
charan III.
24 sitambar 2020 koo, novavex ney britten mein 15,000 key saath ack charan III pareekshan key liye shuru kiya.
disambar 2020 mein novavex ney america aur maxico mein roktham-19 (aine. see. tii. 04611802) charan III pareekshan shuru kiya, jise niyaid aur barda dwara vitt poshit kiya gayaa.
3 maee 2021 koo, novavex ney sanyukt raajya america mein 75 sthalon taka 3,000 kishoron key saath charan III naidaanik pareekshan key liye ack baal chikitsa vistaar shuru kiya.
yuke trial.
28 janwari 2021 koo, novavax ney bataaya kii united kingdam pareekshan key praarambhik parinamon seey pataa chalaa kii iska teeka ummidwar 89 pratishat seey adhik prabhaavi thaa. 
12 march 2021 koo, novavex ney ghoshana kii kii unakaa teeka ummidwar covid-19 key mool tanaav koo rokane mein 96.4% prabhaavi thaa aur alfa sanskaran key khilaf 86 pratishat prabhaavi thaa.
30 juuna 2021 koo, "dha nyu ingland journal off medicine" mein prakaashit ack praathamik novavex-vitt poshit adhyayan seey pataa chalaa kii vaccine kii pahali khuraak key dou saptah baad 83.4% aur doosari khuraak key ack saptah baad 89.7% kii samagr prabhavkarita haye. ack post hock vishleshan ney b.1.1.7 (alfa) sanskaran key khilaf 86.3% aur "gair-b.1.1.7 upbhedon" key khilaf 96.4% kii prabhavkarita dikhaai, jinamen seey adhikansh "prototype upbhedon" (mool upbhedon) they.
dakshin africa mukadama.
28 janwari 2021 koo, novavex ney bataaya kii dakshin africa mein ack pareekshan key antarim parinamon ney beeta sanskaran (vansh b.1.351) key khilaf cumm prabhavsheelta darr dikhaai, lagbhag 50-60% parr.<riff naam = "doee 10.1126/science.aeye. bee. jee. 8101 "> </ref>
march aur maee 2021 mein report kiye gaye ack adhyayan mein, novavex vaccine (nvx-cove2373) kii prabhavkarita kaa pareekshan praarambhik yaadrichhik, placebo-niyantrit adhyayan mein kiya gayaa thaa jisamen 2684 pratibhaagi shamil they joe aadhar rekha pareekshan mein covid key liye nakaratmak they. beeta sanskaran honey vaalaa pramukh sanskaran thaa, jisamen hiv-nakaratmak pratibhagiyon key liye 51.0% key beeta key khilaf novavex kii cross-protective vaccine prabhavkarita kaa sanket post-hock vishleshan key saath thaa.
us aur mexico trial.
14 juuna 2021 koo, novavex ney charan III yuu mein samagr 90.4% prabhavkarita kii ghoshana kii.aiss. mexico pareekshan jisamen 18 varsh aur usase adhik ayu key lagbhag 30,000 loga shamil they. pareekshan pratibhagiyon mein paae gaye kull 77 covid-19 mamalon mein seey, 14 vaccine samooh mein hue, jabaki 63 placebo samooh mein hue.
samaaj aur sanskriti.
novavex covid-19 teeke kii lagbhag 216,000 khuraaken pradhikaran seey 26 juuna 2022 taka eu/eea mein dee gaeen.
kanuni sthiti.
farwari 2021 mein, europeeya dawa agency (ee. aim. aeye.) ney novavex covid-19 vaccine (aine. vee. aiks.-see. oh. vee. 2373) kii ack sameeksha shuru kii. navambar 2021 mein, ee. aim. aeye. koo sashart vipanan pradhikaran key liye aavedan praapt huaa. 20 disambar 2021 koo, europeeya aayog ney europeeya dawa agency (ee. aim. aeye.) kii sifarish key baad, europeeya sangh mein ack sashart vipanan pradhikaran pradaan kiya, taaki ise brand naam nuvaxovid key tahat becha jaa sakey.
navambar 2021 taka, ise bhaarat mein disambar 2022 taka, dakshin koria, australia mein janwari 2022 taka, united kingdam, kanada, taiwan aur singapur mein farwari 2022 taka upayog key liye adhikrit kiya gayaa haye. disambar 2021 taka ise vishva swaasthya sangathan dwara maanya kiya gayaa thaa.
3 juuna 2022 koo, fda kii salaahkaar samiti ney sanyukt raajya america mein vayaskon mein upayog key liye novavex key teeke key pradhikaran kii sifarish karane key liye ack anupasthit key saath 21-0 koo matdan kiya. 
13 julaai 2022 koo, fda ney vayaskon mein praathamik teekaakaran (booster naheen) key roop mein aapaatkaaleen upayog key liye nvx-cove2373 koo adhikrit kiya. ise america mein adhikrit chautha covid19 teeka banaana. 19 julaai 2022 koo, us center forr digies controll aind prevention (cdc) ney 18 varsh aur usase adhik ayu key vayaskon key liye dou-khuraak vaali praathamik shrinkhala key roop mein novavex covid19 vaccine kii sifarish kii, iss prakaar iss vaccine key sambandh mein teekaakaran prathaon (acip) parr salaahkaar samiti kii sifarish kaa samarthan kiya. 19 agast 2022 koo, aff. dee. aeye. ney 12-17 varsh kii ayu key logon mein novavex covid19 teeke key liye aapaatkaaleen upayog pradhikaran pradaan kiya. 22 agast 2022 koo, see. dee. see. ney 12-17 varsh kii ayu key kishoron key liye novavex covid19 teeke kii sifarish kii.